Which enzyme do ACE inhibitors block, and what is the direct consequence for angiotensin II levels?
Choose an answer, then check it.
Clinical Pharmacology · Antihypertensive Medications
ACE Inhibitors
On this page 6 sections
In 30 seconds
ACE inhibitors ("-pril" drugs like lisinopril, enalapril, and ramipril) lower blood pressure by blocking the enzyme that converts angiotensin I into angiotensin II, a powerful vasoconstrictor that also drives sodium and water retention. Because the same enzyme normally breaks down bradykinin, blocking it causes bradykinin to build up — the source of the class's signature dry cough and rare but dangerous angioedema. Beyond hypertension, this class is a cornerstone therapy for heart failure with reduced ejection fraction, post-heart-attack remodeling, and protein-losing kidney disease. Their biggest risks are hyperkalemia, kidney injury in vulnerable patients, and absolute danger to a developing fetus.
The college version
The Renin-Angiotensin-Aldosterone System (RAAS)
Blood pressure and fluid balance are tightly controlled by the RAAS cascade. When the kidneys sense low blood pressure, low sodium delivery, or sympathetic nervous system activation, specialized cells release renin. Renin converts angiotensinogen (made by the liver) into angiotensin I, an inactive precursor. Angiotensin-converting enzyme, found mainly on the surface of lung and vascular endothelium, then converts angiotensin I into angiotensin II, the system's active hormone. Angiotensin II is a potent vasoconstrictor that raises peripheral resistance directly, and it also stimulates the adrenal cortex to release aldosterone, which causes the kidneys to reabsorb sodium and water while excreting potassium. The net effect of an activated RAAS is higher blood pressure and expanded blood volume — useful in true hypovolemia, but harmful when chronically activated in hypertension or heart failure.
How ACE Inhibitors Work
ACE inhibitors block the converting enzyme itself, so angiotensin I accumulates while angiotensin II generation falls. Less angiotensin II means less vasoconstriction (lower peripheral resistance, lower blood pressure) and less aldosterone release (less sodium and water retention, less blood volume expansion). This is the therapeutic mechanism.
The same enzyme, however, has a second job: under the name kininase II, it degrades bradykinin, a peptide that promotes vasodilation and vascular permeability. When ACE is inhibited, bradykinin is not broken down as efficiently and accumulates in tissue. This bradykinin buildup contributes some of the vasodilating benefit of the drug class, but it is also directly responsible for the two most characteristic adverse effects: a dry, persistent, tickling cough, and angioedema, a swelling reaction that can affect the lips, tongue, throat, and airway. Understanding this dual mechanism — angiotensin II suppression as the therapeutic pathway, bradykinin accumulation as the side-effect pathway — explains almost everything distinctive about this drug class.
Naming Stem and Representative Agents
Generic ACE inhibitor names end in the suffix "-pril." Commonly used agents include lisinopril, enalapril, ramipril, captopril, benazepril, and quinapril. They differ somewhat in duration of action and whether they require hepatic activation from a prodrug form, but all share the same core mechanism, side-effect profile, and monitoring needs. Recognizing the "-pril" stem lets a student identify the class instantly, even for an agent not explicitly named.
Indications Beyond Blood Pressure
ACE inhibitors are not simply blood pressure drugs. In heart failure with reduced ejection fraction, reducing angiotensin II and aldosterone lowers the workload the failing heart must pump against and reduces the fluid retention that drives congestion, while also blunting the maladaptive cardiac remodeling that RAAS activation promotes over time. After a myocardial infarction, the same anti-remodeling effect helps preserve ventricular geometry and function, reducing the risk of progression to heart failure. In diabetic and non-diabetic kidney disease with proteinuria, ACE inhibitors preferentially dilate the efferent arteriole of the renal glomerulus, lowering intraglomerular pressure and slowing the protein leakage and structural damage that drive chronic kidney disease progression. These renal and cardiac benefits are considered independent of, and often more clinically important than, the blood pressure–lowering effect alone.
Adverse Effects and Monitoring
The dry cough is the most common reason patients discontinue this class; it is not dangerous but is often bothersome enough to warrant switching to an angiotensin receptor blocker, which spares bradykinin metabolism. Angioedema is uncommon but is a medical emergency because airway swelling can obstruct breathing; it can occur at any point in therapy, even after months of uneventful use, and carries a documented higher incidence in Black patients. Hyperkalemia results from reduced aldosterone-driven potassium excretion and requires monitoring of serum potassium, especially in patients with reduced kidney function or those taking other potassium-raising agents. Acute kidney injury can occur because ACE inhibitors reduce the pressure gradient that maintains glomerular filtration; this risk is magnified in bilateral renal artery stenosis (where the kidney depends heavily on angiotensin II-mediated efferent constriction to maintain filtration), in volume-depleted states, and when combined with NSAIDs and diuretics. First-dose hypotension can occur, particularly in patients who are volume-depleted or already taking diuretics, so the first dose and dose increases warrant closer observation.
Contraindications and Key Interactions
ACE inhibitors are absolutely contraindicated in pregnancy at any trimester because they cause fetal renal injury, oligohydramnios, and other developmental abnormalities. The "triple whammy" interaction refers to the combination of an ACE inhibitor, an NSAID, and a diuretic: each independently affects renal hemodynamics or volume status, and together they substantially raise the risk of acute kidney injury, making this combination one to actively screen for and avoid when possible.
Nursing Considerations
Baseline renal function and potassium level should be established before starting therapy, with follow-up rechecks after initiation and after dose changes. Patients should be counseled to avoid potassium supplements and salt substitutes, many of which are potassium chloride–based, because they compound hyperkalemia risk. Patients should be taught that the characteristic cough is bothersome but not dangerous, while any facial, lip, or throat swelling or difficulty breathing requires immediate medical attention. Blood pressure should be checked before and after dose initiation or titration to catch symptomatic hypotension.
Eli explains
The same idea, in plain words
Explain it like I’m 10
Imagine your body has a delivery truck (angiotensin II) that squeezes the roads (blood vessels) narrower and orders extra water to be picked up and kept in the house (blood volume). ACE inhibitor drugs work by shutting down the factory (the enzyme) that builds this truck. Fewer trucks means wider roads and less water hoarding, so blood pressure comes down.
But that same factory had a second job: cleaning up a different messenger called bradykinin. When the factory shuts down, bradykinin piles up in the throat and airways like leftover packing peanuts nobody swept away. That pile-up is why some people get an annoying tickly cough, and in rare cases, why lips or the throat can swell up dangerously — that swelling is an emergency, like a clogged drain that needs fixing right away.
These medicines also help a tired, overworked heart pump easier, and they protect leaky kidneys, so doctors use them for a lot more than just high blood pressure. But they're never safe for a pregnant person to take, because the growing baby's kidneys can be harmed.
Check yourself
2 review questions from the chapter. Try each one, then open the answer.
A patient with diabetic kidney disease and proteinuria is started on an ACE inhibitor even though her blood pressure is already well controlled. Explain the rationale for this prescribing decision.
Show answer
(sample answer)
ACE inhibitors dilate the kidney's efferent arteriole, which lowers pressure inside the filtering units and reduces protein leakage, slowing kidney damage — a benefit that occurs independent of, and in addition to, blood pressure control.
A nurse is reviewing medication teaching with a patient newly started on an ACE inhibitor who also uses a salt substitute at every meal and takes an over-the-counter NSAID for joint pain. What two concerns should the nurse address, and why?
Show answer
(sample answer)
The nurse should address the salt substitute, which is often potassium-based and can add to the ACE inhibitor's own tendency to raise potassium, and the NSAID, which combined with the ACE inhibitor raises the risk of acute kidney injury, especially if a diuretic is ever added.
Quick check
3 questions here. Answers stay hidden until you check.
A patient on lisinopril calls the clinic reporting a persistent dry cough with no other symptoms. What is the best explanation and appropriate response?
Choose an answer, then check it.
Which combination of medications creates the highest risk of acute kidney injury sometimes called the "triple whammy"?
Choose an answer, then check it.
Study tools & related lessonsRelated
Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.